CRYO-CELL INTERNATIONAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 51.64 thousand shares for the 9-month period ending 2018-08-31, per its 10-Q filed 2018-10-15.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2018-10-15
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2018-08-31 was 0.00 shares, a 100.00% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2018-05-31 was 51.64K shares.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2018-02-28 was 0.00 shares.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2017-11-30 was 2.50K shares.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2017 was 25.00K shares, a 87.79% decline from fiscal 2016.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2016 was 204.73K shares, a 809.91% increase from fiscal 2015.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2015 was 22.50K shares, a 0.00% change from fiscal 2014.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2014 was 22.50K shares, a 37.50% decline from fiscal 2013.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month |
|---|---|---|---|---|
| 2018-08-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-15 | 51.64K shares derived: sum of 2 quarters · filed 2018-10-15 | 51.64K shares 10-Q · filed 2018-10-15 | 54.14K shares derived: sum of 4 quarters · filed 2018-10-15 |
| 2018-05-31 | 51.64K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-16 | 51.64K shares 10-Q · filed 2018-07-16 | 54.14K shares derived: sum of 3 quarters · filed 2018-07-16 | 76.64K shares derived: sum of 4 quarters · filed 2018-07-16 |
| 2018-02-28 | 0.00 shares 10-Q · filed 2018-04-16 | 2.50K shares derived: sum of 2 quarters · filed 2018-04-16 | 25.00K shares derived: sum of 3 quarters · filed 2018-04-16 | 25.00K shares derived: sum of 4 quarters · filed 2018-04-16 |
| 2017-11-30 | 2.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | 25.00K shares derived: sum of 2 quarters · filed 2018-02-28 | 25.00K shares derived: sum of 3 quarters · filed 2018-02-28 | 25.00K shares 10-K · filed 2018-02-28 |
| 2017-08-31 | 22.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-16 | 22.50K shares derived: sum of 2 quarters · filed 2017-10-16 | 22.50K shares 10-Q · filed 2017-10-16 | 22.50K shares derived: sum of 4 quarters · filed 2017-10-16 |
| 2017-05-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-07 | 0.00 shares 10-Q · filed 2017-07-07 | 0.00 shares derived: sum of 3 quarters · filed 2017-07-07 | 35.00K shares derived: sum of 4 quarters · filed 2017-07-07 |
| 2017-02-28 | 0.00 shares 10-Q · filed 2017-04-13 | 0.00 shares derived: sum of 2 quarters · filed 2017-04-13 | 35.00K shares derived: sum of 3 quarters · filed 2017-04-13 | 204.73K shares derived: sum of 4 quarters · filed 2017-04-13 |
| 2016-11-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | 35.00K shares derived: sum of 2 quarters · filed 2017-02-28 | 204.73K shares derived: sum of 3 quarters · filed 2017-02-28 | 204.73K shares 10-K · filed 2017-02-28 |
| 2016-08-31 | 35.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-17 | 204.73K shares derived: sum of 2 quarters · filed 2016-10-17 | 204.73K shares 10-Q · filed 2016-10-17 | 204.73K shares derived: sum of 4 quarters · filed 2016-10-17 |
| 2016-05-31 | 169.73K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-11 | 169.73K shares 10-Q · filed 2016-07-11 | 169.73K shares derived: sum of 3 quarters · filed 2016-07-11 | 192.23K shares derived: sum of 4 quarters · filed 2016-07-11 |
| 2016-02-29 | 0.00 shares 10-Q · filed 2016-04-14 | 0.00 shares derived: sum of 2 quarters · filed 2016-04-14 | 22.50K shares derived: sum of 3 quarters · filed 2016-04-14 | 22.50K shares derived: sum of 4 quarters · filed 2016-04-14 |
| 2015-11-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | 22.50K shares derived: sum of 2 quarters · filed 2016-02-29 | 22.50K shares derived: sum of 3 quarters · filed 2016-02-29 | 22.50K shares 10-K · filed 2016-02-29 |
| 2015-08-31 | 22.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-15 | 22.50K shares derived: sum of 2 quarters · filed 2015-10-15 | 22.50K shares 10-Q · filed 2015-10-15 | |
| 2015-05-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-15 | 0.00 shares 10-Q · filed 2015-07-15 | ||
| 2015-02-28 | 0.00 shares 10-Q · filed 2015-04-14 | |||
| 2014-11-30 | 22.50K shares 10-K · filed 2015-03-02 | |||
| 2013-11-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | 22.50K shares derived: sum of 2 quarters · filed 2014-02-28 | 27.50K shares derived: sum of 3 quarters · filed 2014-02-28 | 36.00K shares 10-K · filed 2014-02-28 |
| 2013-08-31 | 22.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-15 | 27.50K shares derived: sum of 2 quarters · filed 2013-10-15 | 36.00K shares 10-Q · filed 2013-10-15 | 117.00K shares derived: sum of 4 quarters · filed 2013-10-15 |
| 2013-05-31 | 5.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-15 | 13.50K shares 10-Q · filed 2013-07-15 | 94.50K shares derived: sum of 3 quarters · filed 2013-07-15 | |
| 2013-02-28 | 8.50K shares 10-Q · filed 2013-04-15 | 89.50K shares derived: sum of 2 quarters · filed 2013-04-15 | ||
| 2012-11-30 | 81.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | 779.50K shares 10-K · filed 2013-02-28 | ||
| 2012-08-31 | 698.50K shares 10-Q · filed 2012-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |